7月 2026
- 首頁
- Sengenics
7月 2026Sengenics的市場佔有率分析
Contact SomaLogic by exploring our many regions throughout the globe. Contact representatives from Europe, Asia, and the Americas
Sengenics(包含公司地區)
查看更多網站流量與參與度資訊- sengenics.com
Sengenics截至 7月 2026 的總收入為 15M - 25M
Sengenics 熱門網域產生的總收入
Sengenics 熱門網域 3 年內的總收入
Sengenics 熱門網域的總收入
Sengenics的熱門網域總造訪量
了解Sengenics市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
無可顯示數據
無可顯示數據
Sengenics的熱門網域平均造訪時長
分析Sengenics參與度指標。
過去 3 個月平均造訪時長
無可顯示數據
無可顯示數據
Sengenics的熱門網域平均頁面瀏覽量
了解Sengenics如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
無可顯示數據
無可顯示數據
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Sengenics
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Sengenics Corporation LLC. launched i-Ome Cancer, a cutting-edge research tool on Jul 30th '24.BOSTON, July 30, 2024 /PRNewswire/ - Sengenics Corporation LLC is proud to announce the launch of i-Ome Cancer, a cutting-edge research tool designed to transform cancer biomarker discovery using just a drop of blood.
7月 30, 2024閱讀更多
新聞Sengenics Corporation LLC. launched KREX protein folding technology to improve the current state of protein microarray fabrication methodology ( Sengenics | KREX on Jan 1st '08.In 2008, Sengenics introduced the patented KREX protein folding technology to improve the current state of protein microarray fabrication methodology ( Sengenics | KREX | Protein Folding Technology ).
11月 3, 2023閱讀更多
新聞Sengenics Corporation LLC. launched i-Ome Discovery, a comprehensive protein microarray platform on Oct 3rd '23.Sengenics Corporation LLC, a leader in immune response profiling to support scientific discovery and diagnostic development, today announced the launch of i-Ome Discovery, a comprehensive protein microarray platform for the analysis of autoantibodies associated with disease diagnosis and therapeutic intervention.
10月 2, 2023閱讀更多
查看所有Sengenics信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
